ClinicalTrials.gov record
Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.
RECRUITING · NCT05419726
Trial record
NCT IDNCT05419726
Status
RECRUITING
Study type
OBSERVATIONAL
Phase
—
Enrollment
20
Conditions
Obesity
Interventions
Semaglutide Injectable Product (not provided by the study)
Locations
UCLA Health, Los Angeles, California, United States
Indexed topics
Last update
2025-05-06